Welcome to LookChem.com Sign In|Join Free
  • or
(Z)-2-benzoxy-3-(3-hydroxy-3-methylbutyl)-4-methoxy-t-butyl cinnamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1246952-70-4

Post Buying Request

1246952-70-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1246952-70-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1246952-70-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,6,9,5 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1246952-70:
(9*1)+(8*2)+(7*4)+(6*6)+(5*9)+(4*5)+(3*2)+(2*7)+(1*0)=174
174 % 10 = 4
So 1246952-70-4 is a valid CAS Registry Number.

1246952-70-4Downstream Products

1246952-70-4Relevant academic research and scientific papers

CINAMIC COMPOUNDS AND DERIVATIVES THEREFROM FOR THE INHIBITION OF HISTONE DEACETYLASE

-

Page/Page column 15, (2010/10/19)

The invention relates to a compound represented by the following formula (I): and pharmaceutically acceptable salts, stereoisomers, enantiomers, prodrugs and solvates thereof. The compounds are useful as an agent for enhancing the neurite outgrowth and preventing or treating of diseases associated with HDAC in particular, tumor or cell proliferative diseases. In particular, the compounds of the invention can be used as an agent for anti-cancer, anti-diabetic, and anti-neurodegenerative diseases such as Alzheimer's disease, Huntington's disease, Spinocerebellar Ataxias (SCA), and human spinal muscular atrophy (SMA).

Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase

-

Page/Page column 32-33, (2010/10/19)

The invention relates to a compound represented by the following formula (I): and pharmaceutically acceptable salts, stereoisomers, enantiomers, prodrugs and solvates thereof. The compounds are useful as an agent for enhancing the neurite outgrowth and preventing or treating of diseases associated with HDAC in particular, tumor or cell proliferative diseases. In particular, the compounds of the invention can be used as an agent for anti-cancer, anti-diabetic, and anti-neurodegenerative diseases such as Alzheimer's disease, Huntington's disease, Spinocerebellar Ataxias (SCA), and human spinal muscular atrophy (SMA).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1246952-70-4